Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma

Loriot, Y., Sternberg, C. N., Castellano Gauna, D., Dumez, H., Huddart, R., Vianna, K. M., Alonso Gordoa, T., Skoneczna, I. A., Fay, A., Sacco, C. S. P., Nole, F., Massari, F., Brasiuniene, B., Maroto, P., Oosting, S. F., Fear, S., Di Nucci, F., De Ducla, S. & Choy, E., Oct-2019, In : Annals of Oncology. 30, p. 368-369 2 p.

Research output: Contribution to journalMeeting AbstractAcademic

  • Y. Loriot
  • C. N. Sternberg
  • D. Castellano Gauna
  • H. Dumez
  • R. Huddart
  • K. M. Vianna
  • T. Alonso Gordoa
  • I. A. Skoneczna
  • A. Fay
  • C. S. P. Sacco
  • F. Nole
  • F. Massari
  • B. Brasiuniene
  • P. Maroto
  • S. F. Oosting
  • S. Fear
  • F. Di Nucci
  • S. De Ducla
  • E. Choy
Original languageEnglish
Pages (from-to)368-369
Number of pages2
JournalAnnals of Oncology
Publication statusPublished - Oct-2019
Event44th Congress of the European-Society-for-Medical-Oncology (ESMO) - Barcelona, Spain
Duration: 27-Sep-20191-Oct-2019


44th Congress of the European-Society-for-Medical-Oncology (ESMO)


Barcelona, Spain

Event: Conference

ID: 107803742